Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
miriam.lichtner@uniroma1.it
Miriam Lichtner
Professore Ordinario
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
miriam.lichtner@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Infection-related and -unrelated malignancies, HIV and the aging population
HIV MEDICINE
2016
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort
PLOS ONE
2016
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
2016
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort
CLINICAL MICROBIOLOGY AND INFECTION
2016
HCV-related diabetes: Still looking for a definition
CLINICAL MICROBIOLOGY AND INFECTION
2016
Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study
MEDICINE
2016
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
2016
Baseline myeloid and lymphoid activation markers can predict time to viral load reduction under 50 copies/mL and CD4 recovery, respectively, after highly active antiretroviral therapy initiation
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
2016
Cardiovascular risk in HIV-positive subjects: analyses of T-cell phenotype and CD49d expression
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
2016
In the ERA of New Direct Acting Antiviral Agents HCV Sequencing Allows the Most Accurate Subtype and Genotype Assignment
JOURNAL OF HEPATOLOGY
2016
HBV-HDV Co-Infection Constrains HBV Genetic Evolution in HBsAg
JOURNAL OF HEPATOLOGY
2016
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study
THE LANCET. HIV
2016
HBsAg genetic elements critical for immune escape correlate with HBV-reactivation upon immunosuppression
HEPATOLOGY
2015
Multifunctional analysis of CD4+T-cell response as immune-based model for tuberculosis detection
JOURNAL OF IMMUNOLOGY RESEARCH
2015
Genotypic tropism testing in HIV-1 proviral DNA can provide useful information at low-level viremia
JOURNAL OF CLINICAL MICROBIOLOGY
2015
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients
THE JOURNAL OF INFECTIOUS DISEASES
2015
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy
AIDS RESEARCH AND HUMAN RETROVIRUSES
2015
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study
THE LANCET. HIV
2015
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLOS MEDICINE
2015
Evaluation of blood plasmacytoid dendritic cells and inflammatory monocytes during firstwave HCV protease inhibitor therapy
2015
« prima
< precedente
1
2
3
4
5
6
7
seguente ›
ultima »
Progetti di Ricerca
Marcatori di risposta e modificazioni del pattern infiammatorio in una corte di pazienti con polmonite da SARS-Cov2 sottoposti al trattamento con farmaci immunomodulanti
Ruolo dell'immunità innata nell'infezione da SARS-COV2 in una corte di pazienti con polmonite da COVID: biomarkers e correlati clinici
Risposta immune innata e immuno-attivazione T in pazienti coinfetti HIV/HCV sottoposti a farmaci ad azione diretta anti HCV (DAA) Innate immunity and immune activation in HIV/HCV coinfected subjects undergoing DAA
- Impatto dell'eradicazione di HCV nel controllo dell'immunoattivazione residua in pazienti HIV/HCV coinfetti - HCV eradication in HIV/HCV co-infected patients: impact on residual immune-activation.
Immunità mucosale nella donna HIV positiva in terapia antiretrovirale efficace: biomarcatori e correlati clinici Mucosal Immunity in HIV-1 infected women undergoing effective antiretroviral therapy: biomarkers and clinical determinants
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma